Delivery Order SPE2DB22D3016-SPE2DB25FBJF2
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $10,137.08 for Abrysvo vial with diluent syringes. The contract, which carries a firm fixed price structure, was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $14,940.61 firm fixed price delivery order to AmerisourceBergen Drug Corp for Abrysvo vial with diluent syringes. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 11, 2025. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency has awarded a $10,011.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ABRYSVO vials with diluent syringes, with an ultimate completion date of December 11, 2024. This competitively awarded contract, with no set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $6,481.98 to AmerisourceBergen Drug Corp for Abrysvo vial with diluent syringes. This is a firm fixed price, non-set-aside contract issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,601.10 to AmerisourceBergen Drug Corp for Abrysvo vial with diluent syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $15,124.62 to AmerisourceBergen Drug Corp for Abrysvo vial with diluent syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,002.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Abrysvo vial with diluent syringes, with an ultimate completion date of April 9, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 million and extends through December 2026. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $21,288.34 by the Defense Logistics Agency for Abrysvo vial with diluent syringes. This firm fixed price contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a competitively awarded, non-set-aside procurement. The order will be fulfilled at AmerisourceBergen's Conshohocken facility and is expected...
- The Defense Logistics Agency awarded a delivery order valued at $18,216.64 to AmerisourceBergen Drug Corp for Abrysvo vials with diluent syringes, with an ultimate completion date of August 28, 2025. This firm fixed-price contract, awarded without set-aside provisions, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,617.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Abrysvo vial with diluent syringes. The contract, classified as a non-set-aside competitive award, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and falls under the company's...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJF2Delivery Order
The Defense Logistics Agency awarded a $12,346.74 delivery order to AmerisourceBergen Drug Corp for Abrysvo vial with diluent syringes, with an ultimate completion date of September 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company's comprehensive IDC vehicle enables the delivery of a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order for Abrysvo vials with syringes reflects AmerisourceBergen's role in supplying vaccines and specialized medical delivery systems to federal healthcare programs. The company's extensive federal contract portfolio demonstrates its competitive capability and reliability as a prime vendor for diverse medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/14/25 |